The Chemours (CC) Fundamental Analysis: Revenue, Earnings & Valuation

6.03 / 10

Outperform

Fundamental rating is Outperform with a 6.0/10 score. Profit‑MV and Net‑income‑Revenue are bullish, as are cash‑flow growth and current ratio. Cash‑UP and high Cost‑of‑sales ratio are weak points, while equity multiplier shows limited leverage.

Analysis Checks(5/10)

Net cash flow from operating activities per share (YoY growth rate %)

Value141.58

Score3/3

Weight17.64%

1M Return6.06%

Equity multiplier

Value29.53

Score1/3

Weight6.21%

1M Return2.24%

Profit-MV

Value0.68

Score3/3

Weight22.36%

1M Return7.12%

Net income-Revenue

Value-0.04

Score2/3

Weight10.69%

1M Return3.54%

Net cash flow from operating activities (YoY growth rate %)

Value141.71

Score3/3

Weight17.15%

1M Return5.91%

Cash-UP

Value-0.23

Score1/3

Weight-0.82%

1M Return-0.35%

Long-term debt to working capital ratio (%)

Value4.14

Score1/3

Weight3.29%

1M Return1.22%

Cost of sales ratio (%)

Value84.47

Score0/3

Weight-1.68%

1M Return-0.71%

Equity multiplier (DuPont analysis %)

Value18.14

Score1/3

Weight6.50%

1M Return2.32%

Current ratio

Value1.78

Score3/3

Weight18.67%

1M Return6.27%

Is CC undervalued or overvalued?

CC scores 6.03/10 on fundamentals and holds a Discounted valuation at present. Backed by its -93.80% ROE, -6.65% net margin, -7.92 P/E ratio, 12.18 P/B ratio, and -658.70% earnings growth, these metrics solidify its Outperform investment rating.